Abstract
The Nervous System Gene Therapy (UAB) research group and the VHIR Multiple Sclerosis Center of Catalonia are developing a gene therapy capable of reducing the inflammatory response in early and advanced stages of the disease. The results obtained in animal models are encouraging, although further research is needed to optimize the treatment.
| Translated title of the contribution | Gene therapy strategies for multiple sclerosis |
|---|---|
| Original language | Catalan |
| Pages (from-to) | 0001-2 |
| Number of pages | 2 |
| Journal | UAB Divulga |
| Publication status | Published - 2023 |